Classification and account mode: the implication
Confirm both the access method and the margin setting. Retail order eligibility is not the same question as which assets count as collateral.
DN Decision Briefs / Evidence comparison
Paradex vs GRVT
Compare order classification, usable collateral and settlement obligations. A USDC balance can have very different consequences for margin, debt and withdrawals.
What Matters
Compare like with like. Keep the gaps visible.
2 pinned documentation briefs compared by decision condition. Not a live execution test, security audit, exhaustive product inventory or individual eligibility assessment.
Paradex Retail/Pro order treatment and GRVT Single-Asset/Multi-Asset margin are different kinds of settings. This comparison preserves those distinctions and does not equate their accounts, networks or cost schedules.
DN Evidence Block
The conditions side by side.
| Decision factor | Paradex | GRVT |
|---|---|---|
| Classification and account mode | The guide classifies UI and interactive-JWT API submissions as Retail. Standard API submissions default to Pro; exceeding Retail limits changes treatment. Paradex Retail and Pro orders | The MAM guide supports USDT and USDC with collateral haircuts. Single-Asset Mode counts USDT only; enabled collateral and margin balance govern capacity. GRVT multi-asset margin guide |
| Usable collateral and debt | The collateral guide says non-USDC balances contribute to total account value but not free collateral, and USDC is required for perpetual markets. Paradex non-USDC balances and collateral | Perps settle in USDT. Under MAM, a USDT shortfall can trigger automatic borrowing against other collateral, with hourly interest and possible conversion fees. GRVT multi-asset margin guide |
| Fee conditions | The fee page lists zero Retail maker/taker trading fees and a separate Pro schedule. Pro perps/spot maker fees and volume-based taker fees apply. Paradex trading fees | The fee page contains dated schedules and separates spot from perps. Its March 2026 schedule uses 30-day trading-volume tiers and distinguishes maker rebates from taker charges. GRVT fee model |
| Balance and funding interpretation | The collateral guide says non-USDC balances contribute to total account value but not free collateral, and USDC is required for perpetual markets. Paradex non-USDC balances and collateral | The USDC deposit article describes automatic conversion to USDT through Rhino. The newer MAM guide separately describes USDC held as collateral. GRVT USDC deposit routeGRVT multi-asset margin guide |
| Withdrawal conditions | Risk checks constrain withdrawable USDC by free collateral and the account USDC balance. Margin-health checks govern liquidation eligibility. Paradex risk checks | The fee-model page lists network-specific flat amounts. The dedicated transfer-fee article describes Rhino routes as a platform charge plus bridge gas. GRVT fee modelGRVT deposit and withdrawal fees |
| Execution and liquidation limits | Retail orders have documented speed bumps and lower rate limits, with access to Retail Price Improvement liquidity and queue benefits. Pro orders follow different conditions. Paradex Retail and Pro orders | The MAM guide describes automatic conversion or full liquidation when margin requirements are breached. Open-order cancellation should not be assumed to rescue margin first. GRVT multi-asset margin guide |
| What remains unmeasured | This review does not establish individual eligibility, API permission safety or live withdrawal and stop-loss reliability. | This pinned snapshot provides no independent measurements of execution, withdrawal reliability or individual eligibility. |
Usable collateral and debt: the implication
Total account value is not available margin. GRVT USDC collateral does not change USDT settlement; account debt may create additional costs.
Fee conditions: the implication
Match product, order classification and fee tier. Zero commission or a maker rebate cannot establish an all-in cost advantage.
Balance and funding interpretation: the implication
Check the resulting asset after a deposit or conversion. Holding a token, counting it as margin and settling a trade in it are distinct conditions.
Withdrawal conditions: the implication
Use the account-specific withdrawable amount and final route quote. Published balance rules and fee descriptions are not observed payout reliability.
Execution and liquidation limits: the implication
Documented queue treatment and liquidation procedures describe different mechanisms. They do not provide a measured execution or safety ranking.
What remains unmeasured: the implication
Current permissions, individual eligibility and independently observed fills and withdrawals remain unverified.
Evidence boundary
No invented rates. No implied guarantees.
- Matched executable quotes including entry, holding and exit costs
- Independent fill, stop-loss and withdrawal reliability
- Current permissions, recovery and revocation behaviour
- Individual eligibility and current regional restrictions
No numerical all-in cost is calculated. A valid comparison needs contemporaneous quotes for matching assets, product modes, notional sizes, directions and holding periods, with entry, holding and exit costs included.
Your research record
Keep the evidence.
Keep its limits.
The receipt preserves all underlying evidence snapshots and the comparison at version 1.0.0.
It is not a recommendation, approval, live quote or alert subscription. No account, balance, wallet or country is requested.
- Scope
- Perpetual trading across distinct product scopes
- Collateral scope
- Market, account and route dependent. No universal collateral equivalence or shared deployment is asserted.
- Evidence version
- 1.0.0 / 2026-10-14
- Live tested
- No
Change record
Reviewed dates, not inferred launch dates.
DN publication
Initial comparison of pinned documentation snapshots. Evidence coverage differs; unsupported conditions remain unknown.
Review triggers: Changed official product, fee, margin or withdrawal documentation; A substantiated correction; The earliest underlying editorial review deadline. No automated provider surveillance runs for this brief.
How to use this research
Provider-reported describes the source of a statement, not an independent endorsement. Unknown and not measured identify evidence gaps. A documentation review does not confer an operational-status classification or establish user eligibility.
DN may receive compensation through commercial links elsewhere on the site. This comparison has no trading CTA or payout-based ranking. Documentation does not establish current operational status, safety or user eligibility.
Educational research only, not investment, legal or tax advice. Leveraged derivatives can cause substantial losses.